Dam, Merete http://orcid.org/0000-0002-8857-8629
Centanni, Maddalena http://orcid.org/0000-0001-6594-9813
Friberg, Lena E.
Centanni, Daniel http://orcid.org/0009-0001-6179-3361
Karlsson, Mats O.
Stensig Lynggaard, Line http://orcid.org/0000-0002-8584-5920
Johannsdottir, Inga Maria
Wik, Hilde Skuterud
Malmros, Johan
Vaitkeviciene, Goda Elizabeta
Griskevicius, Laimonas
Hallböök, Helene
Jónsson, Ólafur Gísli
Overgaard, Ulrik
Schmiegelow, Kjeld http://orcid.org/0000-0002-0829-4993
Hansen, Stefan Nygaard
Heyman, Mats http://orcid.org/0000-0001-7637-1949
Albertsen, Birgitte Klug http://orcid.org/0000-0002-3902-3694
Funding for this research was provided by:
Børnecancerfonden (2018-3682)
Barncancerfonden (PR2021-0064)
Listed else where
Article History
Received: 15 November 2023
Revised: 5 January 2024
Accepted: 10 January 2024
First Online: 29 January 2024
Competing interests
: Jazz Pharmaceuticals has BKA serving on its advisory board and MD served as a consultant for Servier on a single occasion. All other authors state that they have no conflict of interest.